ASXL1 and chronic myelomonocytic leukemia: Monocytosis, defined by increased monocyte levels, is significant in Chronic Myeloid Leukemia and Chronic Myelomonocytic Leukemia (CML and CMML), with mutations in ASXL1 and NRAS contributing to disease progression [7, 8].